CDKN2A and breast carcinoma: Previous studies have linked effects of breast cancer treatment (chemotherapy and/or radiation) to higher levels of inflammatory markers,12,24–26,33 and separately, to elevated levels of a marker of cellular senescence, p16INK4a.